| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |